Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Equity Ratio (2016 - 2025)

Traws Pharma's Equity Ratio history spans 14 years, with the latest figure at 0.06 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.06 for Q4 2025, up 95.32% from a year ago — trailing twelve months through Dec 2025 was 0.06 (up 95.32% YoY), and the annual figure for FY2025 was 0.06, up 95.32%.
  • Equity Ratio for Q4 2025 was 0.06 at Traws Pharma, down from 0.37 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.83 in Q4 2021 to a low of 5.65 in Q2 2024.
  • The 5-year median for Equity Ratio is 0.58 (2023), against an average of 0.14.
  • The sharpest move saw Equity Ratio plummeted 1010.43% in 2024, then surged 260.55% in 2025.
  • Year by year, Equity Ratio stood at 0.83 in 2021, then fell by 13.51% to 0.72 in 2022, then plummeted by 34.57% to 0.47 in 2023, then crashed by 369.32% to 1.27 in 2024, then surged by 95.32% to 0.06 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.06, 0.37, and 0.53 for Q4 2025, Q3 2025, and Q2 2025 respectively.